COPENHAGEN, Denmark – October 23, 2026 — In the high-stakes arena of global biopharmaceuticals, the line between incremental progress and market-disrupting innovation is often drawn by a single set of clinical trial data. Today, Genmab A/S has firmly plan... See more
Experts would likely conclude that Evergreen's 'hold forever' model offers a viable alternative to traditional private equity roll-ups, particularly for boutique European MSPs struggling with regulatory and talent challenges. HALSTEREN, Netherlands – Octo... See more
NEW DELHI, India – October 21, 2026 — As the global economy grapples with the dual pressures of geopolitical turbulence and the urgent need for decarbonization, the center of gravity for the energy transition is shifting decidedly eastward. From November ... See more
Experts would likely conclude that Northstar's strategic partnership with TAMKO represents a pivotal step in advancing the circular asphalt economy, combining financial backing with operational validation to de-risk industrial decarbonization. CALGARY, AB... See more
Experts would likely conclude that Boeing's Dataliner represents a strategic shift toward decentralized data control in aviation, addressing airline concerns over data sovereignty while leveraging AI for predictive maintenance and operational efficiency. ... See more